Billiontoone (NASDAQ:BLLN) Share Price Breaks Below Fifty Day Moving Average - What's Next?

Key Points

• Billiontoone shares fell below their 50-day moving average, trading as low as $104.35 and last at $105.15, versus a 50-day average of $106.99.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $124.38; seven rate the stock Buy, three Hold, and one Sell.
• Company insiders sold 252,777 shares worth about $26.7 million over the past three months; the CEO’s sale was made under a pre-arranged trading plan.

Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report)'s stock price passed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $106.99 and traded as low as $104.35. Billiontoone shares last traded at $105.15, with a volume of 647,690 shares trading hands.

Analyst Ratings Changes

Several brokerages have recently issued reports on BLLN. Weiss Ratings upgraded Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a research report on Monday, November 9th. JPMorgan Chase & Co. raised their target price on Billiontoone from $130.00 to $135.00 and gave the company an "overweight" rating in a research report on Thursday, November 5th. Wall Street Zen downgraded Billiontoone from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Piper Sandler reduced their price target on Billiontoone from $140.00 to $130.00 and set an "overweight" rating for the company in a research report on Tuesday, November 10th. Finally, BTIG Research reissued a "buy" rating and issued a $130.00 price target on shares of Billiontoone in a research note on Thursday, November 5th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $124.38.

Billiontoone Price Performance

The business's 50-day simple moving average is $106.99 and its 200 day simple moving average is $97.74. The company has a market capitalization of $4.96 billion and a P/E ratio of 114.29. The company has a current ratio of 11.25, a quick ratio of 10.89 and a debt-to-equity ratio of 0.16.

Insider Activity

In related news, CEO Oguzhan Atay sold 25,001 shares of the business's stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $109.24, for a total transaction of $2,731,109.24. Following the sale, the chief executive officer owned 16,667 shares of the company's stock, valued at $1,820,703.08. The trade was a 60.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the company's stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total value of $1,975,400.00. Following the completion of the sale, the chief technology officer owned 1,000 shares of the company's stock, valued at $98,770. This trade represents a 95.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 252,777 shares of company stock worth $26,737,151 over the last three months. Corporate insiders own 50.22% of the company's stock.

Hedge Funds Weigh In On Billiontoone

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Marshall Wace LLP boosted its holdings in Billiontoone by 620.0% during the third quarter. Marshall Wace LLP now owns 321,546 shares of the company's stock worth $34,225,000 after buying an additional 276,884 shares in the last quarter. Aberdeen Group plc acquired a new position in Billiontoone in the third quarter worth approximately $19,565,000. Wasatch Advisors LP increased its holdings in shares of Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company's stock valued at $62,160,000 after buying an additional 148,446 shares in the last quarter. State Street Corp increased its holdings in shares of Billiontoone by 101.7% in the third quarter. State Street Corp now owns 144,075 shares of the company's stock valued at $15,335,000 after buying an additional 72,639 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new position in shares of Billiontoone in the first quarter valued at $4,046,000.

Billiontoone Company Profile

BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company's molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient's blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.